Evidence for safety of retreatment with a single intra-articular injection of Gel-200 for treatment of osteoarthritis of the knee from the double-blind pivotal and open-label retreatment clinical trials

BACKGROUND: Gel-200 is a cross-linked hyaluronate single-injection device for treatment of osteoarthritis pain in the knee. This report summarizes new analyses of the safety of retreatment with Gel-200 from the 13-week, pivotal, multicenter, randomized controlled trial (RCT) followed by an open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Lim, Sooyeol, Takamura, Junko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888617/
https://www.ncbi.nlm.nih.gov/pubmed/27250845
http://dx.doi.org/10.1186/s12891-016-1101-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888617/
https://www.ncbi.nlm.nih.gov/pubmed/27250845
http://dx.doi.org/10.1186/s12891-016-1101-0

Ejemplares similares